Aizon AI helps drive key pharma manufacturing process and global vaccination SHARE The global vaccination against COVID-19 is one of the biggest challenges ever faced by the pharmaceutical industry. In addition to managing the complexity of clinical trials and the supply chain involved in vaccine manufacturing, companies need to scale production at great speed while complying with regulations in multiple countries. Business challenges like these are the target of startup Aizon, an artificial intelligence software provider that develops AI-powered solutions and analytics to optimize life science manufacturing. “The main problem when you want to do a scale-up process is not only the equipment, it is also the knowledge that you have around your process,” said Toni Manzano (pictured), co-founder and chief scientific officer of Aizon. “AI is helping nowadays in order to detect and to identify the most relevant factors involved in the process, the critical relationship between the variables and the final control of all the full process following a continued process verification.”